Literature DB >> 23404576

Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.

Luciana da Silva Ruiz1, Sonia Khouri, Rosane Christine Hahn, Eriques Gonçalves da Silva, Vanessa Krummer Perinazzo de Oliveira, Rinaldo Ferreira Gandra, Claudete Rodrigues Paula.   

Abstract

Opportunistic infections are an increasingly common problem in hospitals, and the yeast Candida parapsilosis has emerged as an important nosocomial pathogen. The aims of this study were to determine and compare (i) the prevalence rate among C. parapsilosis complex organisms isolated from blood in a public children's hospital in São Paulo state, (ii) the ability of the complex C. parapsilosis species identified to produce biofilm and (iii) the antifungal susceptibility profiles. Forty-nine (49) specimens of isolated blood yeast were analyzed, previously identified as C. parapsilosis by conventional methods. After the molecular analysis, the isolates were characterized as C. parapsilosis sensu stricto (83.7 %), C. orthopsilosis (10.2 %) and C. metapsilosis (6.1 %). All species were able to form biofilm. The species with the highest biofilm production was C. parapsilosis sensu stricto, followed by C. orthopsilosis and further by C. metapsilosis. All of the strains have demonstrated similar susceptibility to fluconazole, caspofungin, voriconazole, cetoconazole and 5-flucytosine. Only one strain of C. parapsilosis was resistant to amphotericin B. Regarding itraconazole, 66.6 and 43.9 % isolates of C. metapsilosis and C. parapsilosis, respectively, have demonstrated to be susceptible dose-dependent, with one isolate of the latter species resistant to the drug. Candida parapsilosis sensu stricto has demonstrated to be the less susceptible, mainly to amphotericin B, caspofungin and "azoles" such as fluconazole. Therefore, C. metapsilosis and C. orthopsilosis are still involved in a restricted number of infections, but these data have become essential for there are very few studies of these species in Latin America.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404576     DOI: 10.1007/s11046-013-9616-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  38 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.

Authors:  Analy S Melo; Fernando C Bizerra; Edna Freymüller; Beth A Arthington-Skaggs; Arnaldo L Colombo
Journal:  Med Mycol       Date:  2010-11-02       Impact factor: 4.076

3.  Prevalence and distribution profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis responsible for superficial candidiasis in a Chinese university hospital.

Authors:  Xiaobo Feng; Bo Ling; Guimei Yang; Xia Yu; Daming Ren; Zhirong Yao
Journal:  Mycopathologia       Date:  2011-11-19       Impact factor: 2.574

4.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 5.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

6.  Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.

Authors:  A Gomez-Lopez; A Alastruey-Izquierdo; D Rodriguez; B Almirante; A Pahissa; J L Rodriguez-Tudela; M Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

7.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

8.  Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital.

Authors:  Thomas A Clark; Sally A Slavinski; Juliette Morgan; Timothy Lott; Beth A Arthington-Skaggs; Mary E Brandt; Risa M Webb; Mary Currier; Richard H Flowers; Scott K Fridkin; Rana A Hajjeh
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.

Authors:  Serhat Marol; Mine Yücesoy
Journal:  Mycoses       Date:  2008-01       Impact factor: 4.377

10.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

View more
  17 in total

1.  Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.

Authors:  Maria Helena G Figueiredo-Carvalho; Leonardo S Barbedo; Manoel M E Oliveira; Fábio Brito-Santos; Rodrigo Almeida-Paes; Rosely M Zancopé-Oliveira
Journal:  Mycopathologia       Date:  2014-06-22       Impact factor: 2.574

2.  Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Authors:  S J Taj-Aldeen; A Kolecka; R Boesten; A Alolaqi; M Almaslamani; P Chandra; J F Meis; T Boekhout
Journal:  Infection       Date:  2013-12-19       Impact factor: 3.553

3.  Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.

Authors:  Maria Emilia Cattana; Catiana Dudiuk; Mariana Fernández; Florencia Rojas; Liliana Alegre; Susana Córdoba; Guillermo Garcia-Effron; Gustavo Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 4.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

5.  The Pathogenic Yeast Candida parapsilosis Forms Pseudohyphae through Different Signaling Pathways Depending on the Available Carbon Source.

Authors:  Christopher B Rupert; Laura N Rusche
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

6.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

7.  Antimicrobial activity of Aspilia latissima (Asteraceae).

Authors:  Jeana M E Souza; Marilene R Chang; Daniela Z Brito; Katyuce S Farias; Geraldo A Damasceno-Junior; Izabel C C Turatti; Norberto P Lopes; Edson A Santos; Carlos A Carollo
Journal:  Braz J Microbiol       Date:  2015 Oct-Dec       Impact factor: 2.476

8.  Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.

Authors:  Vanessa Kummer Perinazzo Oliveira; Luciana da Silva Ruiz; Nélio Alessandro Jesus Oliveira; Débora Moreira; Rosane Christine Hahn; Analy Salles de Azevedo Melo; Angela Satie Nishikaku; Claudete Rodrigues Paula
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

9.  The identification and differentiation of the Candida parapsilosis complex species by polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer region of the rDNA.

Authors:  Leonardo Silva Barbedo; Maria Helena Galdino Figueiredo-Carvalho; Mauro de Medeiros Muniz; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

10.  Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Ferry Hagen; Jacques F Meis; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.